Status:
COMPLETED
A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP)
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Olympic Medical
National Institutes of Health (NIH)
Conditions:
Cholestasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study it to conduct a randomized, controlled, double-blinded trial of carbon dioxide (CO2) versus air insufflation during endoscopic retrograde cholangiopancreatography (ERCP).
Eligibility Criteria
Inclusion
- age \>= 18 years
- referred for ERCP for any indication at UNC Hospitals
Exclusion
- age \< 18 years
- COPD requiring oxygen or with known CO2 retention
- any medical condition with known CO2 retention
- medical instability making the procedure unsafe
- absolute requirement for same-day second endoscopy
- ERCP performed in the OR or under GA
- inability to read or understand English
- use of chronic opiates for pain
- pregnant women
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00685386
Start Date
June 1 2008
End Date
February 1 2009
Last Update
January 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina-Chapel Hill
Chapel Hill, North Carolina, United States, 27599